Pfizer Inc. (ETR:PFE)
24.95
+0.08 (0.32%)
Feb 21, 2025, 5:41 PM CET
Pfizer Revenue
In the year 2024, Pfizer had annual revenue of $63.63B USD with 8.77% growth. Pfizer had revenue of $17.76B in the quarter ending December 31, 2024, with 24.66% growth.
Revenue
$63.63B
Revenue Growth
+8.77%
P/S Ratio
n/a
Revenue / Employee
$723.03K
Employees
88,000
Market Cap
142.60B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 5.13B | 8.77% |
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 22.67B |
Merck KGaA | 20.96B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Pfizer News
- 12 hours ago - Pfizer: No More Growth - Still A Worthy Dividend Buy - Seeking Alpha
- 1 day ago - Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes - Benzinga
- 1 day ago - Pfizer: Investors Won't Stick Around Forever - Seeking Alpha
- 1 day ago - Pfizer board approves marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane in India - Business Upturn
- 2 days ago - Pfizer said to be discontinuing Roche-partnered hemophilia therapy Beqvez - Seeking Alpha
- 2 days ago - Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports - Reuters
- 2 days ago - Dividend Harvesting Portfolio Week 207: $20,700 Allocated, $2,010.09 In Projected Dividends - Seeking Alpha
- 3 days ago - 10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers - Seeking Alpha